Genealogical tracing of founder variants linked to cardiomyopathies in a South African cohort

Simple item page
dc.contributor.advisorShaboodien, Gasnat
dc.contributor.advisorNtusi, Ntobeko
dc.contributor.authorHoughton, Abbey
dc.date.accessioned2025-11-20T13:48:41Z
dc.date.available2025-11-20T13:48:41Z
dc.date.issued2025
dc.date.updated2025-11-20T13:45:33Z
dc.description.abstractIntroduction: Cardiomyopathies are a major cause of heart failure in South Africa, yet their prevalence, causes, and outcomes remain poorly understood. The IMHOTEP registry was established to clinically and genetically characterise affected patients and through this study several common pathogenic variants were identified, suggesting potential founder variants. This study aimed to genealogically trace the origins of these variants in the probands and their families. Methods: Participants were recruited from South African tertiary hospitals, with baseline data recorded at enrolment. Next generation sequencing identified several probands with possible founder variants which prompted haplotype construction and genealogical tracing. Variants were identified in the genes PKP2, LMNA, BAG3 and TTN and three microsatellite markers, spanning the 5', intergenic and 3' regions, were designed for each of the genes of interest in order to perform haplotype analysis. Genealogical data was collected using online resources, genealogy databases, and the voter's roll. Results: Five PKP2 c.1162C>T (p.Arg388Trp), BAG3 c.925C>T (p.Arg309Ter), LMNA c.568C>T (p.Arg190Trp), TTN c.87624C>G (p.Tyr29208Ter), and TTN c.95008C>T (p.Arg31670Ter) possible founder variants were identified in 38 probands (12 probands with the PKP2 variant; 3 probands with BAG3 variant, three probands with LMNA variant and 20 probands with the two TTN variants). PKP2 was traced to Afrikaner families of Dutch/French Huguenot descent from the 1600s. BAG3 was linked to French-Huguenot and Canadian ancestry. LMNA tracing was limited due to the number of families as well as limited Mixed-Ancestry family records. TTN variants had issues with haplotyping and genealogical challenges as well as limited records for Black African and Mixed-Ancestry families. Conclusions: This research significantly advances our understanding of cardiomyopathy genetics in South Africa. The identification of Dutch/French and French-Canadian ancestries associated with the PKP2 and BAG3 variants, respectively, provides valuable insights into the historical origins and population-specific genetic landscape of these cardiomyopathies. This ancestral information not only deepens our understanding of cardiomyopathy in the region but also has important implications for risk assessment and genetic counselling. By identifying common progenitors, we can better target screening efforts and provide more accurate risk assessments for individuals carrying these founder variants
dc.identifier.apacitationHoughton, A. (2025). <i>Genealogical tracing of founder variants linked to cardiomyopathies in a South African cohort</i>. (). University of Cape Town ,Faculty of Health Sciences ,Department of Medicine. Retrieved from http://hdl.handle.net/11427/42286en_ZA
dc.identifier.chicagocitationHoughton, Abbey. <i>"Genealogical tracing of founder variants linked to cardiomyopathies in a South African cohort."</i> ., University of Cape Town ,Faculty of Health Sciences ,Department of Medicine, 2025. http://hdl.handle.net/11427/42286en_ZA
dc.identifier.citationHoughton, A. 2025. Genealogical tracing of founder variants linked to cardiomyopathies in a South African cohort. . University of Cape Town ,Faculty of Health Sciences ,Department of Medicine. http://hdl.handle.net/11427/42286en_ZA
dc.identifier.ris TY - Thesis / Dissertation AU - Houghton, Abbey AB - Introduction: Cardiomyopathies are a major cause of heart failure in South Africa, yet their prevalence, causes, and outcomes remain poorly understood. The IMHOTEP registry was established to clinically and genetically characterise affected patients and through this study several common pathogenic variants were identified, suggesting potential founder variants. This study aimed to genealogically trace the origins of these variants in the probands and their families. Methods: Participants were recruited from South African tertiary hospitals, with baseline data recorded at enrolment. Next generation sequencing identified several probands with possible founder variants which prompted haplotype construction and genealogical tracing. Variants were identified in the genes PKP2, LMNA, BAG3 and TTN and three microsatellite markers, spanning the 5', intergenic and 3' regions, were designed for each of the genes of interest in order to perform haplotype analysis. Genealogical data was collected using online resources, genealogy databases, and the voter's roll. Results: Five PKP2 c.1162C>T (p.Arg388Trp), BAG3 c.925C>T (p.Arg309Ter), LMNA c.568C>T (p.Arg190Trp), TTN c.87624C>G (p.Tyr29208Ter), and TTN c.95008C>T (p.Arg31670Ter) possible founder variants were identified in 38 probands (12 probands with the PKP2 variant; 3 probands with BAG3 variant, three probands with LMNA variant and 20 probands with the two TTN variants). PKP2 was traced to Afrikaner families of Dutch/French Huguenot descent from the 1600s. BAG3 was linked to French-Huguenot and Canadian ancestry. LMNA tracing was limited due to the number of families as well as limited Mixed-Ancestry family records. TTN variants had issues with haplotyping and genealogical challenges as well as limited records for Black African and Mixed-Ancestry families. Conclusions: This research significantly advances our understanding of cardiomyopathy genetics in South Africa. The identification of Dutch/French and French-Canadian ancestries associated with the PKP2 and BAG3 variants, respectively, provides valuable insights into the historical origins and population-specific genetic landscape of these cardiomyopathies. This ancestral information not only deepens our understanding of cardiomyopathy in the region but also has important implications for risk assessment and genetic counselling. By identifying common progenitors, we can better target screening efforts and provide more accurate risk assessments for individuals carrying these founder variants DA - 2025 DB - OpenUCT DP - University of Cape Town KW - Medicine LK - https://open.uct.ac.za PB - University of Cape Town PY - 2025 T1 - Genealogical tracing of founder variants linked to cardiomyopathies in a South African cohort TI - Genealogical tracing of founder variants linked to cardiomyopathies in a South African cohort UR - http://hdl.handle.net/11427/42286 ER - en_ZA
dc.identifier.urihttp://hdl.handle.net/11427/42286
dc.identifier.vancouvercitationHoughton A. Genealogical tracing of founder variants linked to cardiomyopathies in a South African cohort. []. University of Cape Town ,Faculty of Health Sciences ,Department of Medicine, 2025 [cited yyyy month dd]. Available from: http://hdl.handle.net/11427/42286en_ZA
dc.language.isoen
dc.language.rfc3066eng
dc.publisher.departmentDepartment of Medicine
dc.publisher.facultyFaculty of Health Sciences
dc.publisher.institutionUniversity of Cape Town
dc.subjectMedicine
dc.titleGenealogical tracing of founder variants linked to cardiomyopathies in a South African cohort
dc.typeThesis / Dissertation
dc.type.qualificationlevelMasters
dc.type.qualificationlevelMSc
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
thesis_hsf_2025_houghton abbey.pdf
Size:
17.51 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.72 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Masters